跳至主要内容
临床试验/NCT00632554
NCT00632554已完成4 期

Phase 4, Randomized Study of Three Months-prednisolone Therapy in the Treatment of Chronic Eosinophilic Pneumonia

Hamamatsu University1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2008年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
50
试验地点
1
主要终点
Efficacy of 3 versus 6 months-prednisolone therapy for chronic eosinophilic pneumonia

研究概览

简要总结

A comparison of 3 months-prednisolone administration with 6 months-prednisolone therapy in the treatment of chronic eosinophilic pneumonia. Three months-prednisolone administration may be as effective as 6 months-therapy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
16 Years 至 80 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Biopsy-proven chronic eosinophilic pneumonia

排除标准

  • Patients who received oral glucocorticosteroid (more than 10 mg)
  • Immunosuppressive drug

研究组 & 干预措施

1

Experimental

prednisolone therapy for three months

干预措施: prednisolone 0.5 mg/kg/day for three months (Drug)

2

Active Comparator

prednisolone therapy for six months

干预措施: prednisolone 0.5 mg/kg/day for six months (Drug)

结局指标

主要结局

Efficacy of 3 versus 6 months-prednisolone therapy for chronic eosinophilic pneumonia

时间窗: Three years

次要结局

  • Safety of 3 versus 6 months-prednisolone therapy for chronic eosinophilic pneumonia(Three years)

研究者

发起方
Hamamatsu University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Naoki Inui

Department of Respiratory Medicine

Hamamatsu University

研究点 (1)

Loading locations...

相似试验